Addus HomeCare Corporation (ADUS) - Stock Analysis
Last updated: Mar 14, 2026
Research Idea
Research content for general circulation. Not individualized advice. Methodology & Disclosures
Addus HomeCare posted 21.8% YoY revenue growth in Q2 2025, margin expansion, reduced leverage, and strong cash flow. It benefits from favorable reimbursement rate hikes and recent acquisitions, with bullish technical trends signaling positive momentum ahead of a November 3 earnings release.
Loading chart data...
AI Analyst Overview
Loading chart data...
Valuation Metrics
Fundamental Analysis
Key Financial Insights: ⢠Strong FCF ⢠Moderate leverage ⢠Receivables concentration ADUS generates strong cash and operating margins with positive ROA/ROE but carries valuation premium and balance-sheet risk from large intangibles and sizable receivables.
Price Behavior
Key Price Behavior Insights: ⢠Below moving average ⢠Rapid peak-to-trough ⢠Tight near-term support Support Level: $99.7â$103.5 Resistance Level: $112â$118 Over the last month the stock sits below its last month SMA (~$107.30), having plunged from a $117.63 peak to $99.74 and signaling short-term downside with support around $99.7â$103.5 and resistance at $112â$118.
Sentiment & News
Key News Insights: ⢠Revenue surge ⢠EPS/EBITDA beat ⢠Rising short interest Addus reported a strong quarter and year with revenues +25.6% to $373.1M, adjusted EPS/EBITDA beats and active investor engagement amid rising short interest.
AI Summary
Recast Addus as a cash-generating, M&A-enabled platform rather than a pure organic personal-care operator: near-term upside now depends critically on timely integration of tuckâins, capturing state Medicaid/PCS rate tailwinds, and defending margins against caregiver wage inflation. Actively monitor receivables/collections trends and upcoming state reimbursement actions as the single biggest downside trigger, and consider buying on dips only if management demonstrates repeatable integration synergies and stable collections. #CashM&Aâ
Description
Addus HomeCare provides in-home personal care, hospice, and home health services to elderly, chronically ill, disabled people and those at risk of hospitalization in the United States. Its Personal Care unit supplies non-medical assistance with daily living activities, the Hospice unit delivers palliative and family support services, and the Home Health unit offers skilled nursing and rehabilitative therapies. The company contracts with government programs, managed care organizations, commercial insurers and private clients, and as of December 31, 2021 operated 206 offices in 22 states; it was founded in 1979 and is based in Frisco, Texas.
Idea History
| Date | Close | Ticker | Company | Summary | Status | P/L |
|---|---|---|---|---|---|---|
| Oct 20 | Oct 27 | ADUS | Addus HomeCare Corporation | Addus HomeCare posted 21.8% YoY revenue growth in Q2 2025, margin expansion, reduced leverage, and strong cash flow. It benefits from favorable reimbursement rate hikes and recent acquisitions, with bullish technical trends signaling positive momentum ahead of a November 3 earnings release. | Closed | +0.0% |